Stay updated on Brensocatib in Non-CF Bronchiectasis: Efficacy Clinical Trial
Sign up to get notified when there's something new on the Brensocatib in Non-CF Bronchiectasis: Efficacy Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FmyG2x6V2e0bWPUwVbKkrPwMxzcc.uncropped.jpg&w=3840&q=75)
Latest updates to the Brensocatib in Non-CF Bronchiectasis: Efficacy Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayChange DetectedThe website has added detailed eligibility criteria and study design information for a clinical trial on Brensocatib, including specific inclusion and exclusion criteria for participants aged 12 to 85, as well as the primary and secondary outcome measures related to pulmonary exacerbations.SummaryDifference24%
- Check67 days agoNo Change Detected
- Check68 days agoNo Change Detected
- Check81 days agoChange DetectedThe value 'Ex' has recently changed to 'type of intervention'. This change possibly represents an update related to medical and healthcare-related interventions in the study.SummaryDifference88%
Stay in the know with updates to Brensocatib in Non-CF Bronchiectasis: Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brensocatib in Non-CF Bronchiectasis: Efficacy Clinical Trial page.